Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-4 Registration of securities issued in business combination transactions
- 2.6 Form of Voting Agreement -Nuvelo
- 2.7 Form of Voting Agreement - Arca Biopharma
- 23.1 Consent of Ernst & Young LLP
- 23.2 Consent of KPMG LLP
- 23.3 Consent of KPMG LLP
- 99.2 Consent of Richard B. Brewer
- 99.3 Consent of Michael R. Bristow, M.D., PH.D.
- 99.4 Consent of John L. Zabriskie, PH.D.
- 99.5 Consent of J. William Freytag, PH.D.
- 99.7 Consent of David G. Lowe, PH.D.
- 99.9 Consent of Jefferies & Company, Inc.
ORKA similar filings
- 18 Jun 24 Registration of securities issued in business combination transactions (amended)
- 13 May 24 Registration of securities issued in business combination transactions
- 24 Nov 08 Registration of securities issued in business combination transactions (amended)
- 30 Oct 08 Registration of securities issued in business combination transactions
- 13 Dec 02 Registration of securities issued in business combination transactions (amended)
- 27 Nov 02 Registration of securities issued in business combination transactions
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
The Board of Directors and Stockholders
Nuvelo, Inc.:
We consent to the use of our report dated March 15, 2006, with respect to the consolidated statements of operations, stockholders’ equity, and cash flows of Nuvelo, Inc. and subsidiary for the year ended December 31, 2005, included herein and to the reference to our firm under the heading “Experts” in the proxy statement/prospectus/consent solicitation.
/s/ KPMG LLP
San Francisco, California
October 27, 2008